Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H44N2O3 |
| Molecular Weight | 384.5964 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O
InChI
InChIKey=IWKZTTDNVPAHNP-FQEVSTJZSA-N
InChI=1S/C22H44N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-21(25)24-19-16-15-17-20(23)22(26)27/h20H,2-19,23H2,1H3,(H,24,25)(H,26,27)/t20-/m0/s1
| Molecular Formula | C22H44N2O3 |
| Molecular Weight | 384.5964 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity. | 2004 Nov |
|
| Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. | 2007 Aug 22 |
|
| Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity. | 2010 Jun 21 |
|
| A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes. | 2010 Mar 1 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:31:05 GMT 2023
by
admin
on
Sat Dec 16 06:31:05 GMT 2023
|
| Record UNII |
58KUR4D1LL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
58KUR4D1LL
Created by
admin on Sat Dec 16 06:31:05 GMT 2023 , Edited by admin on Sat Dec 16 06:31:05 GMT 2023
|
PRIMARY | |||
|
59012-44-1
Created by
admin on Sat Dec 16 06:31:05 GMT 2023 , Edited by admin on Sat Dec 16 06:31:05 GMT 2023
|
PRIMARY | |||
|
100425
Created by
admin on Sat Dec 16 06:31:05 GMT 2023 , Edited by admin on Sat Dec 16 06:31:05 GMT 2023
|
PRIMARY |